Loading…

High-Dose Ampicillin-Sulbactam Combinations Combat Polymyxin-Resistant Acinetobacter baumannii in a Hollow-Fiber Infection Model

is emerging with resistance to polymyxins. In 24-h time-kill experiments, high-dose ampicillin-sulbactam in combination with meropenem and polymyxin B achieved additivity or synergy against 10 CFU/ml of two clinical isolates resistant to all three drugs (maximum reductions, 1.6 and 3.1 logs). In a 1...

Full description

Saved in:
Bibliographic Details
Published in:Antimicrobial agents and chemotherapy 2017-03, Vol.61 (3)
Main Authors: Lenhard, Justin R, Smith, Nicholas M, Bulman, Zackery P, Tao, Xun, Thamlikitkul, Visanu, Shin, Beom S, Nation, Roger L, Li, Jian, Bulitta, Jürgen B, Tsuji, Brian T
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:is emerging with resistance to polymyxins. In 24-h time-kill experiments, high-dose ampicillin-sulbactam in combination with meropenem and polymyxin B achieved additivity or synergy against 10 CFU/ml of two clinical isolates resistant to all three drugs (maximum reductions, 1.6 and 3.1 logs). In a 14-day hollow-fiber infection model, high-dose ampicillin-sulbactam (8/4 g every 8 h, respectively) in combination with meropenem (2 g every 8 h) and polymyxin B (1.43 mg/kg of body weight every 12 h with loading dose) resulted in rapid (96 h) eradication of .
ISSN:0066-4804
1098-6596
DOI:10.1128/AAC.01268-16